RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance
Author:
Funder
National Cancer Institute
National Institute of Allergy and Infectious Diseases
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference41 articles.
1. Ribosomopathies—defective ribosome biogenesis and diseases;N. Kenmochi;Seikagaku,2013
2. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor;S Rao;Lin28B. Blood,2012
3. Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs;Y Zhang;Dev Cell,2013
4. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint;SJ Anderson;Immunity,2007
5. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma;S Rao;Cancer research,2016
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Arsenic trioxide regulates the glycolytic pathway to treat acute promyelocytic leukemia by inhibiting RPL22L1;Leukemia Research;2024-09
2. RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway;Aging;2024-08-28
3. Ribosomal RNA transcription governs splicing through ribosomal protein RPL22;2024-08-16
4. RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4;Cell Reports;2024-08
5. Leishmania Ribosomal Protein (RP) paralogous genes compensate each other’s expression maintaining protein native levels;PLOS ONE;2024-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3